Epigenetic drugs for Alzheimer's disease

British Journal of Clinical Pharmacology

Volumn 75, Issue 4, 2013, Pages 1152-1153

  Peedicayil, Jacob ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; EPIGENETIC DRUG; FOLIC ACID DERIVATIVE; HISTONE DEACETYLASE INHIBITOR; METHYLFOLATE; S ADENOSYLMETHIONINE; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ARTICLE; DNA METHYLATION; EPIGENETICS; GENE EXPRESSION; HISTONE ACETYLATION; LEARNING; MEMORY; NUTRIENT; PRIORITY JOURNAL;

ALZHEIMER DISEASE; DRUG DISCOVERY; EPIGENESIS, GENETIC; HUMANS; MOLECULAR TARGETED THERAPY;

EID: 84875062630     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04444.x     Document Type: Article

References (8)

1. Salomone S, Caraci F, Leggio GM, Fedotova J, Drago F. New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. Br J Clin Pharmacol 2012; 73: 504-517.
2. Vlaming H, van Leeuwen F. Crosstalk between aging and the epigenome. Epigenomics 2012; 4: 5-7.
3. Day JJ, Sweatt JD. Epigenetic treatments for cognitive impairments. Neuropsychopharmacology 2012; 37: 247-260.
4. Daniilidou M, Koutroumani M, Tsolaki M. Epigenetic mechanisms in Alzheimer's disease. Curr Med Chem 2011; 18: 1751-1756.
5. Zawia NH, Lahiri DK, Cardozo-Pelaez F. Epigenetics, oxidative stress, and Alzheimer's disease. Free Radic Biol Med 2009; 46: 1241-1249.
6. Abel T, Zukin RS. Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr Opin Pharmacol 2008; 8: 57-64.
7. Xu K, Dai X-L, Huang H-C, Jiang Z-F. Targeting HDACs: a promising therapy for Alzheimer's disease. Oxid Med Cell Longev 2011; 2011: 143269.
8. Peedicayil J. Role of epigenetics in pharmacotherapy, psychotherapy and nutritional management of mental disorders. J Clin Pharm Ther 2012; 37: 499-501.